Biocorrx Stock Today
| BICX Stock | USD 0.30 0.01 3.23% |
PerformanceSoft
| Odds Of DistressRisky
|
BioCorRx is trading at 0.3 as of the 16th of February 2026; that is 3.23 percent decrease since the beginning of the trading day. The stock's open price was 0.31. BioCorRx has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 18th of November 2025 and ending today, the 16th of February 2026. Click here to learn more.
BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. The company has 7.63 M outstanding shares. More on BioCorRx
Moving against BioCorRx OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BioCorRx OTC Stock Highlights
| CEO | Brady Granier |
| Business Concentration | Medical Care Facilities, Healthcare (View all Sectors) |
BioCorRx [BICX] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Micro-Cap' category with a current market capitalization of 11.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioCorRx's market, we take the total number of its shares issued and multiply it by BioCorRx's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BioCorRx conducts business under Healthcare sector and is part of Medical Care Facilities industry. The entity has 7.63 M outstanding shares.
BioCorRx currently holds about 81.76 K in cash with (3.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check BioCorRx Probability Of Bankruptcy
Ownership AllocationThe market capitalization of BioCorRx is $11.82 Million. BioCorRx retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check BioCorRx Ownership Details
BioCorRx Risk Profiles
| Mean Deviation | 9.63 | |||
| Semi Deviation | 11.44 | |||
| Standard Deviation | 18.41 | |||
| Variance | 338.99 |
BioCorRx Stock Against Markets
Picking the right benchmark for BioCorRx otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in BioCorRx otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for BioCorRx is critical whether you are bullish or bearish towards BioCorRx at a given time. Please also check how BioCorRx's historical prices are related to one of the top price index indicators.
BioCorRx OTC Stock Analysis Notes
About 59.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.69. BioCorRx last dividend was issued on the 22nd of January 2019. The entity had 1:100 split on the 22nd of January 2019. BioCorRx Inc., through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States. The company was formerly known as Fresh Start Private Management, Inc. and changed its name to BioCorRx Inc. in January 2014. Biocorrx operates under Medical Care Facilities classification in the United States and is traded on OTC Exchange.The quote for BioCorRx is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on BioCorRx please contact Brady Granier at 714 462 4880 or go to https://www.biocorrx.com.BioCorRx Investment Alerts
| BioCorRx is way too risky over 90 days horizon | |
| BioCorRx has some characteristics of a very speculative penny stock | |
| BioCorRx appears to be risky and price may revert if volatility continues | |
| BioCorRx has a very high chance of going through financial distress in the upcoming years | |
| BioCorRx currently holds 174.16 K in liabilities with Debt to Equity (D/E) ratio of 5.72, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. BioCorRx has a current ratio of 0.08, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist BioCorRx until it has trouble settling it off, either with new capital or with free cash flow. So, BioCorRx's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BioCorRx sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BioCorRx to invest in growth at high rates of return. When we think about BioCorRx's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 48.27 K. Net Loss for the year was (5.21 M) with profit before overhead, payroll, taxes, and interest of 42.39 K. | |
| BioCorRx currently holds about 81.76 K in cash with (3.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 59.0% of BioCorRx shares are held by company insiders |
BioCorRx Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 11.82 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioCorRx's market, we take the total number of its shares issued and multiply it by BioCorRx's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 16th of February 2026, BioCorRx shows the Risk Adjusted Performance of 0.0441, mean deviation of 9.63, and Downside Deviation of 18.74. BioCorRx technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down nineteen technical drivers for BioCorRx, which can be compared to its peers.BioCorRx Price Movement Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. BioCorRx Tanh Of Price Series is a hyperbolic price transformation function.
BioCorRx Outstanding Bonds
BioCorRx issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BioCorRx uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BioCorRx bonds can be classified according to their maturity, which is the date when BioCorRx has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
BioCorRx Predictive Daily Indicators
BioCorRx intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BioCorRx otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 0.97 | |||
| Day Median Price | 0.3 | |||
| Day Typical Price | 0.3 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) |
BioCorRx Forecast Models
BioCorRx's time-series forecasting models are one of many BioCorRx's otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BioCorRx's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Be your own money manager
Our tools can tell you how much better you can do entering a position in BioCorRx without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
Additional Tools for BioCorRx OTC Stock Analysis
When running BioCorRx's price analysis, check to measure BioCorRx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioCorRx is operating at the current time. Most of BioCorRx's value examination focuses on studying past and present price action to predict the probability of BioCorRx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioCorRx's price. Additionally, you may evaluate how the addition of BioCorRx to your portfolios can decrease your overall portfolio volatility.